W
estern societies are experiencing an epidemic of congestive heart failure (CHF) due to better treatment options for patients with acute cardiovascular disease and general progressive aging of the population. [1] [2] [3] [4] Clinical trials have demonstrated poor prognosis in patients with CHF, which reflects an optimistic estimate compared with the prognosis in community-based populations. 4, 5 Recently, community-based 1-, 2-, 5-, and 7-year survival rates of 74%, 65%, 45% and 32%, respectively, were found for CHF patients in The Netherlands compared with 97%, 94%, 80%, and 70% in a matched reference group of people without CHF. 4 In addition, CHF has a substantial impact on daily functioning, health-related quality of life, and health care use, apart from the consequences of aging. 6 Because CHF touches nearly every important aspect of daily life, patients are engaged to improve their self-management abilities and to take responsibility for day-to-day self-management. According to one of the first definitions, the term "self-management," which is often used interchangeably with the term "self-care," indicates patients' active participation in (chronic) disease treatment. [7] [8] [9] In general, CHF self-management comprises 4 areas: (1) treatment (eg, adherence to prescribed medications), (2) self-monitoring (eg, daily weighing), (3) lifestyle modifications (eg, adhering to diet restriction and exercise), and (4) symptom recognition (eg, dyspnea, edema). [9] [10] [11] [12] When patients' exercise intolerance leads to activity restriction and progressive functional deterioration, physical activity may interrupt this downward spiral and improve functional capacity and quality of life. 13 Diet and lifestyle changes may prevent complications and hospitalization, thus slowing the progression of disease. niques, and relaxation can play an important role in daily CHF self-management. 14 Therefore, self-management seems necessarily complementary to professional health care for CHF patients. Unfortunately, many CHF patients fail to adhere to the complex treatment regimen. [15] [16] [17] Many intervention programs have been developed and evaluated to improve self-management behavior in CHF patients. Some of these-such as telephone-or home-based interventions, [18] [19] [20] programs in clinical (outpatient) settings, [21] [22] [23] and groupbased programs [24] [25] [26] -have demonstrated positive outcomes on health-related quality of life. However, most intervention programs solely emphasize the medical aspects of CHF self-management (eg, symptom recognition), whereas patients face equal difficulties in dealing with the social and emotional consequences of CHF. 27, 28 The Chronic Disease Self-Management Program (CDSMP) focuses on the medical (ie, physical), social, and emotional consequences of being chronically ill and emphasizes the patients' central role and responsibility in managing their illness on all 3 levels. 8, [29] [30] [31] The CDSMP is based on Bandura's 32 self-efficacy theory and teaches patients 3 self-management skills: (1) how to manage the medical consequences of the disease (medical management, eg, medication adherence and lifestyle changes, such as exercising regularly), (2) how to remain socially active in daily life (role management), and (3) how to manage the emotional consequences of being chronically ill (emotional management). 31 Currently the CDSMP is a well known and widely disseminated group-based program aimed at helping people with various chronic conditions to achieve a positive and active self-management lifestyle by enhancing their self-efficacy expectancies. [33] [34] [35] [36] [37] [38] [39] Previous studies have found favorable effects of the CDSMP on outcomes, such as self-efficacy expectancies, health behavior, and hospitalization, in heterogeneous groups of patients with chronic diseases, including patients with cardiovascular diseases (eg, coronary artery disease and CHF) and patients with chronic lung disease (eg, asthma and emphysema). 8, [29] [30] [31] The effectiveness and feasibility of the program, however, have not yet been assessed among a group comprised solely of CHF patients.
We expect that CHF patients can benefit from this self-management program because increasing self-management skills in this group of patients may positively influence their self-care, their healthrelated quality of life (ie, physical, social, and emotional functioning), and their health care use. Furthermore, lower levels of self-efficacy expectancies seem to predict functional decline in CHF patients, which could be altered by attending the program. 40 Finally, by emphasizing social and emotional aspects of self-management as well, the program is based on a more holistic definition of self-management, which corresponds to a greater level of the day-to-day management of CHF than most selfmanagement programs that have been previously tested among CHF patients. In fact, psychosocial factors may even be the key in effective CHF management. 27, 28, 41 Although the CDSMP was originally developed for use in heterogeneous patient groups, the program also seems applicable to a more homogeneous setting of patients with cardiovascular disease. 42 Therefore, we assessed the effects of the CDSMP on psychosocial attributes (eg, self-efficacy expectancies), health behavior (eg, self-care), quality of life, and health care use solely among CHF patients in a randomized controlled trial (n ϭ 317). 43 A detailed process evaluation was performed alongside this trial to assess the feasibility of the CDSMP among patients and leaders and to assess the factors predicting good attendance in this population. CHF patients often experience decreased exercise capacity, which may negatively influence attendance. Based on the results of this process evaluation, we make recommendations for increasing program feasibility (if necessary) and improving patients' attendance to facilitate implementation of the program in regular outpatient care (ie, regular checkups with the cardiologist and/or the CHF nurse specialist).
METHODS Participants
The process evaluation was performed among 186 CHF patients (who were assigned to 1 of the 21 CDSMP classes) and 18 leaders (9 professional leaders and 9 peer leaders) who conducted the program during the intervention period after they had been trained for 4 days in the CDSMP protocol. 43 The professional leaders were cardiac nurse specialists. They conducted the CDSMP classes in combination with their usual work in the hospital. The peer leaders were CHF patients who had New York Heart Association (NYHA) class II and III symptoms. The patients in the study were selected from the heart failure and/or cardiology outpatient clinics of 6 participating hospitals in the southern part of The Netherlands from October 2004 to January 2006. The hospitals were located within 86 km from the study site and were comparable with regard to clinical and outpatient care facilities (ie, regular checkups with the cardiologist and/or the CHF nurse specialist) for CHF patients with NYHA class II and III symptoms. Patients were eligible for the study if they had CHF for at least 6 months based on systolic or diastolic dysfunction (plus an additional hospital admission for decompensatio cordis after CHF diagnosis based on diastolic dysfunction) and experienced slight to marked limitations in physical activity (NYHA class II and III symptoms). There was no exclusion based on time interval from CHF diagnosis. A more detailed description of the selection of the patients and training of the leaders has been published elsewhere. 43 
Intervention
The CDSMP is a structured group-based program addressing general management problems for patients with chronic conditions. The program consists of 6 weekly sessions (2.5 hours/session) and teaches patients to become active self-managers in medical, role, and emotional management. 31 Regarding medical management, topics such as medication usage, making informed treatment decisions, and making a personal exercise plan are addressed. Topics to improve remaining socially active are, for example, action-planning and communication skills. Finally, topics such as dealing with anger, fear, and frustration and depression management are addressed to focus on emotional management issues. Table I lists the CDSMP activities for each session. 44 Self-efficacy is considered the key mechanism of the CDSMP because self-efficacy and self-efficacy expectancies are associated with changes in health behavior and status. 8, 32 To enhance self-efficacy expectancies, the program incorporates 4 strategies, namely skills mastery, reinterpretation of symptoms, modeling, and social persuasion. 8, 31 Skills mastery includes goal-setting, making weekly action plans, and feedback, which takes up approximately 25% to 35% of each session. The program aims at motivating patients to make behavioral changes by setting personal goals and breaking them down into smaller steps (action plans). At each session the patients in the group are invited to make their own personal, yet reasonable, action plans, which must be achieved before the next session, eg, walking 3 blocks after dinner every other day. To check reasonability of the action plan and maximally improve the chance for success, patients are questioned plenary about their confidence level to entirely complete their action plan. If the confidence level is too low (Ͻ7 on a scale of 0 to 10), problem-solving of barriers takes place, and the action plan is adjusted. During the next session, the action plans for the past week are discussed, and problem-solving takes place in a group brainstorm exercise if participants failed to accomplish their action plan. During each session, patients are invited to make a new weekly action plan. Goal-setting and action-planning is encouraged during the sessions; however, the participants' decision to make and complete an action plan is entirely voluntary, which emphasizes the patients' responsibility in managing their chronic condition in daily life. 44 Patients are supported in action-planning through supportive telephone calls from co-participants. Furthermore, patients are encouraged to set an exercise goal and to create a personal exercise program during the program.
Reinterpreting symptoms comprises cognitive symptom-management techniques and deals with modifying patients' beliefs about their symptoms to help to relieve symptom problems. The modeling and social-persuasion aspects of the program support and motivate patients to make these changes in their behaviors and beliefs, eg, those patients who are skeptical about making action plans. 44 In addition, Lorig et al developed a reference book, Living a Healthy Life With Chronic Conditions.
14 This book was translated into Dutch together with the program protocol. 45 The patients received this book during the first program session. During each session, patients were invited to read the part of the book covering the contents of that particular session.
In our study, all CDSMP classes were led by a team comprising a cardiac nurse specialist (professional leader) and a CHF patient (peer leader), who acted as a role model for the other CHF patients. Normally, CDSMP classes are led by 2 trained volunteer lay leaders (who may be chronically ill). However, in light of future implementation of the program in Dutch health care, we expect that including a professional leader will facilitate this implementation. Furthermore, because CHF is a serious and life-threatening disease, CHF peer leaders may only be able to conduct the program for a limited period, which could form a serious problem regarding continuity of the program. The format and contents of the intervention protocol, as well as the design of the randomized controlled trial, have been described in more detail elsewhere.
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Measurements
To determine the program's feasibility, 3 main outcome measures were assessed among patients and/or leaders: (1) the extent to which the program was performed according to protocol, (2) patients' adherence to the program, and (3) leaders' and participants' opinions about the program. Data from patients who attended at least half of the program were collected directly after the program and again 1 year after the start of the program by means of self-administered questionnaires. Data from the leaders were collected during and directly after the program by means of recording forms and self-administered questionnaires (Table II) . In addition, the leaders discussed program experiences in bimonthly structured meetings and in a structured group interview at the end of the intervention period using semistructured evaluation forms.
Performance according to protocol. Regarding performance according to protocol, the leaders recorded for each session whether they deviated from protocol (eg, exceeded specified time limits per activity or skipped activities). In addition, they recorded preparation time and time spent on the session itself.
Patients' and leaders' opinions about the program. Patients' adherence to the program was assessed by measuring patients' attendance, overall patients' Observed mean ϭ 132 minutes (range 115 to 165) Activity 3 Working with your health care professional Activity 4 Looking back and planning for the future Activity 5 Closing adherence during the sessions, and patients' adherence to homework assignments. Each session the leaders reported on patients' attendance. Absent patients were called on the phone by the professional leaders to ask the reason for absence. Reasons for withdrawal before the start of the intervention or for stopping during the intervention period were also recorded. In addition, for each session the leaders reported on overall adherence to the program (ie, patients' efforts during the program sessions) at the group level (5-point scale: "very good" to "very poor"). Directly after completing the program, both leaders and patients reported on adherence to homework assignments. The patients reported on the number of action plans they created and accomplished successfully during the program and reported whether they made a personal exercise program. The leaders reported on the number of patients who developed weekly action plans and accomplished them successfully (both 4-point scale: "most participants in the group" to "nobody in the group").
Patients' opinions about the program. Directly after the program, patients were asked to what extent they had benefited from the program (5-point scale:
"did not benefit" to "benefited very much") and which parts of the program they did or did not appreciate. In addition, patients were asked (1) to give report marks for the quality of the professional and peer leaders as well as the program itself (range 1 [low] to 10 [high]); (2) whether they would recommend the program to other CHF patients or to patients with other chronic diseases (eg, diabetes mellitus); and (3) whether the program contributed to improvement of specific health behaviors and coping strategies (ie, "perceived benefits") compared with before they attended the program (2-point scale: "yes" or "no"). Finally, the patients were asked for suggestions to improve the program. After 1 year, the patients received a short questionnaire to re-evaluate the CDSMP (eg, perceived benefits) in the previous 12 months.
The leaders gave report marks for each session and for the program as a whole, and they reported on the strengths and weaknesses of the sessions. In addition, the leaders gave report marks for their own leadership skills, gave their opinion about patients' perceived benefits of the program (3-point scale: "most participants in the group improved" to "nobody in the group improved"), and made recom- 
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Group-based self-management program for CHF patients mendations for improvement of the program. Finally, the leaders evaluated the feasibility of the protocol (eg, regarding co-leadership and session duration and frequency) and made recommendations to improve the program in a structured group interview at the end of the intervention period.
Data analysis
Data were analyzed by means of descriptive statistics. Regarding the prediction of attendance patients who attended Ն4 sessions (ie, high attenders) were compared with patients who attended Ͻ4 sessions (ie, low attenders). Three types of variables, which had been assessed at baseline, were used to assess attendance to the program: (1) sociodemographic variables (sex, age, living arrangements, and education level), (2) health-related variables (health-related quality of life, self-care behavior, cognitive status, and NYHA classification), and (3) psychosocial variables (symptoms of anxiety and feelings of depression, self-efficacy expectancies, and perceived control). These measures have been described in more detail elsewhere. 43 Univariate analyses were conducted to compare both groups on sociodemographic, health-related, and psychosocial variables using Student t test for independent samples, chi-square test, and MannWhitney U test. Characteristics of the leaders, ie, sex, age, and education level, were obtained. In addition, NYHA class and time interval from CHF diagnosis were obtained from the CHF peer leaders. The analyses were performed using SPSS for Windows, version 12.0.1 (Chicago, IL).
RESULTS
Participant characteristics
Mean patient age (n ϭ 186) was 66.6 years (SD 11.0; range 29 to 87). The majority of patients were men (76% [n ϭ 141]), did not live alone (67%), were not employed (91%), and had a secondary (vocational) education (64%). Approximately two thirds of patients (65%) experienced NYHA class II symptoms (slight physical limitation). The majority of the professional leaders were female (78% [n ϭ 7]), and all peer leaders were male; mean ages were 45.6 (SD 5.2) and 58.1 (SD 10.5) years, respectively. Professional leaders had a tertiary (vocational) education, and the majority of the peer leaders had a secondary/tertiary (vocational) education (77.7%). Eight of 9 peer leaders experienced NYHA class II symptoms, and the mean time interval from CHF diagnosis was 
Performance according to protocol
The mean number of participants allocated per class was 8.9 (range 7
classes. An absent peer leader was not replaced unless this occurred during the first session of the program. This exception was made because of the modeling role of the peer leader during the first session in particular. In addition, leaders stated that 101 of 126 sessions (80%) were carried out according to protocol. Only small protocol deviations were reported, with the exception being session 4 during which, in 12 of the 21 CDSMP classes, the activities "advance directives for health care" (eg, in an end-of-life situation) and "communication skills" overran the allotted time in the protocol. These activities were considered difficult topics to comprehend or to focus on by the participants. This resulted in not performing according to protocol or skipping it because of lack of time or participant motivation. In the other 9 classes, no substantial deviations were mentioned in session 4. Five of 6 sessions took more time on average than allotted per the protocol (Table I) . However, our CDSMP classes were smaller; therefore, more time could be spend per participant compared with the amount of time per class reported by Lorig et al. [29] [30] [31] The mean time per session was 140 minutes, which corresponded well with the time allotted per protocol (calculated mean 136). Furthermore, the range of duration of the sessions varied substantially (100 to 180 minutes), whereas the duration of sessions per protocol varied from 125 to 145 minutes (Table  I) . Mean preparation time was 46 minutes/session/ leader (range 0 to 180). In general, peer leaders needed slightly more time to prepare for a session than professional leaders (52 vs 40 minutes, respec-tively). The amount of preparation time depended on the leader's protocol routine and decreased during the intervention period.
Patients' adherence to the program and patients' and leaders' opinions of the program
Patients' attendance. In total, 79% of patients (n ϭ 146) attended at least half of the program, and 47% (n ϭ 88) attended all 6 sessions of the program.
Of the 146 patients who attended at least half of the program, 138 (95%) completed the first evaluation form to assess adherence to homework assignments and gave their opinion about the program. After 1 year, 86% (n ϭ 126) of patients responded to the second evaluation form. 
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Group-based self-management program for CHF patients (Table III) . Regarding homework assignments, the leaders reported that "most participants in the group" made weekly action plans and successfully accomplished these action plans on a weekly basis as well (not tabulated). Of the patients who made a personal exercise program during the program, 46%
(n ϭ 58) was still exercising according to their personal exercise program at 1 year after the program (Table III) .
Patients' opinions about the program. Tables IV to VI list the main findings with regard to opinions about and perceived benefits of the program. Over-
Table IV
Patients' opinions and recommendations
Program opinions Main findings regarding patients' opinions at FU1
Benefited from CDSMP (n ϭ 138) (%) insert tabs between chapters (n ϭ 3) Target group Patient characteristics: account for large age differences (n ϭ 7) Co-participants: partner to improve understanding complexity disease, family member (n ϭ 6) Time interval from CHF diagnosis: after first admission to hospital, 6 months after diagnosis (n ϭ 3) No recommendations (n ϭ 48) 
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all, most patients (73%) reported directly after the program having benefited (relatively) much from the sessions. They gave a mean report mark of 8.1 for the program. Thirty-eight patients first mentioned action-planning as a strong point of the program. In contrast, 30 patients stated that they did not appreciate the cognitive symptom-management techniques, particularly guided imagery, which was a guided imagination for relaxation; that they were already familiar with most of the content; or that they should have attended the program earlier in their illness process. Patients were positive about the quality of the leaders, and the professional leaders received a somewhat higher overall score (8.3) than the peer leaders (7.9) (Table IV) . A majority of the patients confirmed that the program had improved specific health behaviors and coping strategies. More than 80% of the pa- *FU1 ϭ follow-up directly after the program; FU2 ϭ follow-up after 12 months. 1 Percentage of leaders who agreed that "most participants in the group improved this health behavior/coping strategy as a result of attending the program." tients perceived themselves as being able to improve their physical condition, to use action plans, to deal with their condition(s) more effectively, and to exercise more after they had attended the program (Table V) . Finally, patients were asked to suggest improvements to the program, and most addressed the format of the CDSMP, the protocol content, and the group of patients to which the program was targeted. Most comments were given on spending more time on specific topics (n ϭ 14); taking patients' different characteristics into account because patients experienced rather large differences between themselves and other patients in the class (n ϭ 7); and inviting partners or family members to attend the program (n ϭ 6) (Table IV) . After 1 year, the majority of patients confirmed their opinion that the program was still contributing positively to their specific health behaviors and coping strategies. However, the number of patients who thought that the program was still contributing to their using action plans and exercising more was considerably decreased (58% vs 82% and 69% vs 81%, respectively; Table V) . In contrast, patients reported that the program was still (and even slightly more) contributing to sensible medicine use, following diet instructions, and using cognitive symptom-management techniques to lessen physical complaints 1 year later (Ͼ5% improved percentages). Overall, 75% of patients still benefited (relatively) much from the program at 1 year. Other findings were that in the past year, on average, patients occasionally used the book, Living a Healthy Life With Chronic Conditions," 14 as a reference source, and 12% of the patients reported having made and kept contact with one or more of the participants after completing the program. Finally, at least half 
of patients (n ϭ 69) reported that they would prefer a "booster" session at 6 months (48%) or at 12 months (49%) after attending the program (not tabulated).
Leaders' opinions about the program. Both professional and peer leaders had favorable opinions about leading the CDSMP together. They each had complementary tasks during the program sessions: The professional leaders responded to medical issues, whereas peer leaders shared personal experiences and motivated participants to share their own personal experiences. The main strength of the program sessions was considered the patients' positive and active attitudes during the sessions (n ϭ 91). The main weakness of the program was related to group dynamics: managing specific disturbing patients and/or managing the group in general (n ϭ 54) (Table VI) . On average (64% of the classes; range 43% to 78%; table V), leaders reported that according to their perception, most patients in the group had benefited from the program. However, when comparing these results with the patients' perceived benefits, in general they were more cautious in their opinions than were the patients themselves. Finally, leaders made some recommendations regarding the CDSMP format, the protocol contents, and the target group. Most recommendations addressed adjusting specific activities (n ϭ 7), taking patients' different characteristics into account (n ϭ 5), and taking additional time for individual input from patients (n ϭ 4). Based on the results of the structured group interview about the CDSMP format, the majority of leaders (n ϭ 14) did not suggest improving the duration and frequency of the sessions per protocol. Ten leaders suggested having a maximum of 10 participants/group, whereas other leaders preferred larger groups of participants to improve patients' interactions during the program (not tabulated).
Determinants of attendance
In total, 140 of 186 patients (75%) attended Յ4 of the 6 sessions; 46 patients attended Ͻ4 sessions. The percentage of women was significantly greater among patients who attended Ն4 sessions compared with patients who attended Ͻ4 sessions (28% vs 13%; P ϭ .042). No significant differences were found between the 2 patient groups in age, living arrangements, and education level. Fewer patients with NYHA class III symptoms attended Ն4 sessions compared with those who attended Յ3 sessions (31% vs 48%; P ϭ .044). No significant differences were found for health-related quality of life, self-care behavior, and cognitive status nor for symptoms of anxiety and feelings of depression, self-efficacy expectancies, and perceived control as assessed at baseline. We further determined that NYHA classification and sex were not interrelated.
DISCUSSION
This evaluation study showed that the program was considered feasible according to both patients and leaders. Feasibility was based on (1) positive outcomes from the leaders regarding practicability of the CDSMP protocol, (2) positive outcomes regarding patients' attendance and adherence (ie, overall adherence to the program and homework assignments) according to both patients and leaders; and (3) positive opinions about the CDSMP from both patients and leaders. Patients and leaders were asked questions about adherence to homework assignments as well as their opinions about the program. Their answers corresponded largely because both patients and leaders responded positively about action-planning. In addition, their recommendations included points of agreement, ie, taking additional time for specific topics and improving individual input during these activities as well as taking patients' different characteristics into account.
To gain insight into long-term adherence to the program and perceived benefits of the program, we conducted a second evaluation after 1 year. This second evaluation showed that long-term perceived benefits of the program seemed to diminish to some extent, particularly those benefits representing the components of the program that patients most appreciated directly after the program: actionplanning and exercise activities (Table V) . In contrast, we found improved percentages for the contribution of the program to sensible medicine use, following diet instructions, and using cognitive symptom-management techniques 1 year later compared with percentages measured directly after the program. In addition, the patients reported still benefiting relatively much from the program content after 1 year (Table VI) .
Finally, subgroup analysis revealed that female sex and lower NYHA classification (indicating less severe CHF symptoms) predicted good attendance at the program. Other sociodemographic, healthrelated, and psychosocial variables were not related to attendance. It seems plausible that patients with NYHA class III symptoms may attend fewer sessions because of their marked limitation of physical activity. These results indicate that special attention should be paid to specify the patient-selection criteria for this program in more detail.
LIMITATIONS
Regarding the original intervention, we made one important adaptation in our choice of who lead the program: The CDSMP classes in our study were led by teams consisting of a cardiac nurse specialist (professional leader) and a CHF patient (peer leader) instead of 2 trained volunteer lay leaders. CHF patients were included in the team to improve modeling in the CDSMP classes. Including CHF peer leaders may have affected the program's continuity negatively in terms of attendance at the program sessions and overall availability for the program. Compared with volunteer lay leaders, there may be a greater chance for CHF peer leaders to not attend all 6 sessions of the program because CHF has an erratic and unpredictable course, eg, patients have a 5-fold increased risk of sudden death. 4, 5 In addition, CHF peer leaders may conduct the program only for a limited period after being extensively trained in CDSMP protocol. 43 Training CHF peer leaders may therefore be less efficient compared with training volunteer lay leaders. Therefore, we included a nurse specialist in the team not only to facilitate implementation of the program in regular health care in The Netherlands but also to positively influence program continuity. This seemed to be a justified choice: On 9 occasions, the peer leader was absent because of illness or other reasons, which affected program continuity to some extent and therefore was considered a limitation of the study. Furthermore, replacement of the peer leader was difficult because we needed to conduct 21 consecutive CDSMP classes with a limited number of peer leaders. Not replacing an absent peer leader (with exception of the first program session) was considered a second limitation of the study. Therefore, developing and maintaining a volunteer structure of CHF patients to co-lead the CDSMP might be challenging. By including professional leaders in the program, we improved the continuity of the program; at no time during the study period was a single session cancelled because of program leader unavailability. Furthermore, based on the results of the structured group interview and consistent with previous findings, 42 both professional and peer leaders had favorable opinions about co-leading the CDSMP. Our findings are in accordance with those of Lorig et al, 37 who recently reported that even the maintenance of a volunteer structure by using peer leaders was difficult to develop and maintain. Toward the end of their study period, combined professional and peer co-leadership became more common as well.
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RECOMMENDATIONS
Based on the results of this study, we can make 4 recommendations. First, we recommend reconsidering the sequence of the activities in session 4 -"advance directives for health care," "communication skills," and "problem-solving"-and simplifying the contents of these activities. In more than half of the classes, participants had difficulties dealing with these topics or even lost motivation to attend these activities. By 2006, some small revisions had already been made to the original CDSMP protocol, 44 including a sequence revision and content revision of the activities in session 4. 46 Our findings support these modifications.
Second, we recommend extending the time spent on several CDSMP topics and allowing more time for the exchange of personal patients' experiences. Particularly the time spent on activities such as "medication age," "healthy eating," and "advance directives for health care (eg. in an end-of-life situation)" could be extended to patients' benefit. CHF patients might need to discuss these topics more extensively because the self-management process is challenging for these patients, and their self-management abilities might be poor at the outset. 17, 47 Furthermore, CHF patients are more likely to be facing death than other chronically ill patient groups. In fact, CHF has a higher mortality rate than many cancers and an equivalent symptom burden and severity. 48 In addition, CHF patients often have poorer understanding of their prognosis and experience difficulties discussing end-of-life issues. 49, 50 Third, we recommend that the target group for CDSMP classes be specified more in detail for CHF patients to create more homogenous groups of patients. Some patients experienced rather large differences between themselves and other patients in the class regarding age and perceived CHF symptoms. Although social comparison seems inevitable, because all participants in our study had the same chronic condition, matching specific patient characteristics, such as age or NYHA classification, might improve patients' exchange of personal experiences. Preferably, subgroups should be defined as to who would benefit most from the CDMSP and who would attend classes more regularly. What might be recommended in specifying the target group is to select "Time interval from CHF diagnosis" because some patients specifically would have preferred attending the program earlier after diagnosis (n ϭ 3) or were already familiar with most of the content by the time they attended the program (n ϭ 9). When selecting future patients for the program, special attention should be given to informing, facilitating, and motivating the male participants having more severe CHF symptoms (NYHA class III) because they showed a relatively low attendance rate in our study. Furthermore, allowing partners of CHF patients to attend the program might improve patients' attendance. In addition, some patients (n ϭ 6) recommended more involvement of partners or family members. Although the CDSMP protocol allows partners or family members to attend the program, we did not specifically invite them for logistic reasons.
Based on our findings, we do not recommend specifying the content of the intervention for various CHF patient groups (eg, NYHA class). More in-depth analyses (Student t test for independent samples) showed that NYHA class II and III CHF patients did not differ in their perceptions of how much they benefited from the program ("relatively much" 71.0% and 77.8%, respectively; P ϭ 0.702); the mean number of action plans made (4.4 and 4.2, respectively; P ϭ 0.412) and accomplished (3.8 and 3.7, respectively; P ϭ 0.649) per patient; and mean report mark for the program (8.1 and 8.0, respectively; P ϭ 0.609). Furthermore, the original CDSMP was designed as a generic program and is based on self-tailoring, eg. through personal action-planning. 8 Our last recommendation refers to adding a booster session to the CDSMP 6 or 12 months after attending the program because we found that the perceived benefits of the program regarding actionplanning and exercising diminished somewhat in the long term. Furthermore, immediately after the program, 4 patients recommended adding booster sessions to the program. In addition, at the second evaluation, Ͼ50% of the patients reported that they would have preferred a booster session at 6 or 12 months after the class. Patients also mentioned that they had not frequently used the CDSMP reference book during the year after the program and that only a few of them had kept contact with class members. In this booster session, daily experiences from the previous 1-year period could be exchanged; some of the main self-management techniques could be practiced again (eg, action-planning and cognitive symptom-management techniques); and new exercise goals and action plans could be made. However, future research is needed to study whether adding such a booster session would increase effectiveness of the program in the long term (ie, 1 year after the class).
COMMENTS
This study reported on the feasibility of the CDSMP 8, [29] [30] [31] among CHF patients with NYHA class II and III symptoms. The program emphasizes patients' central role and responsibility in managing their own illness and teaches patients to become active self-managers, which is crucial for CHF selfmanagement. Based on the results of our study, this comprehensive group-based program seems applicable to a homogeneous patient group of CHF patients with NYHA class II and III symptoms in The Netherlands. Future research could focus on exploring the surplus value of a booster session and assessing determinants of attendance and adherence to the program, eg, including more time for patient exchange of personal experiences, by specifying the target group more in detail, or by allowing partners of CHF patients to attend the program as well.
